I 48 ugers- analysen var det virologiske respons (HIV- 1 RNA < 50 kopier/ ml) 83, 7% for PREZISTA/ ritonavir - og 78, 3% for lopinavir/ ritonavir- behandlingsarmen.
In the 48 week analysis, the virologic response (HIV-1 RNA < 50 copies/ml) for the PREZISTA/ritonavir arm was 83.7% and for the lopinavir/rtv arm 78.3%.